Category: Uncategorized

At the CLEI Center for Keratoconus, Dr. Hersh and his staff are involved in a number of educational programs for keratoconus doctors and patients. In the Fall of 2012, we will sponsor our 8th Annual Keratoconus Patient Symposium in association with the National Keratoconus Foundation. In a very successful program last year, nearly 150 keratoconus […]

Dr. Hersh visited Moscow hospital this week to review results of new corneal cross-linking technique.

In the June issue of Journal of Refractive Surgery, Dr. Hersh’s article, “Effect of Topographic Cone Location on Outcomes of Corneal Collagen Cross-linking for Keratoconus and Corneal Ectasia.” Corneal collagen cross-linking is a treatment designed to decrease the progression of keratoconus and corneal ectasia. The purpose of the article is to assess the effect of […]

Dr. Hersh discusses positive early outcomes for cross-linking with a corneal implant for keratoconus and ectasia in an article for Ocular Surgery News. At the American Academy of Opthalmology meeting, Dr. Hersh presented his early results iof patients who were treated with Intacs and CXL in either combination or subquential. Dr. Hersh discusses Early outcomes […]

Dr. Hersh will be giving a lecture entitled “Clinical Timecourse of Corneal Collagen Crosslinking” at the annual meeting of the Association of Research in Vision and Ophthalmology on Wedneday May 9. He will be presenting results of his work on the corneal crosslinking procedure which is designed to treat keratoconus. Keratoconus is a disorder that […]

As you get older, it becomes harder and harder to read without glasses. In some cases, LASIK can help. Even if you have had LASIK before, it often can be retreated to improve your vision further. Dr. Hersh has been performing laser vision correction for 20 years and has had many patients who benefit from […]

Dr. Hersh presented several lectures at the ASCRS symposium in Chicago this past weekend. On Thursday evening, he presented the results of a clinical study looking at the use of intacs in conjuction with corneal collagen crosslinking (CXL) on the treatment of keratoconus and corneal ectasia. On Saturday morning he led the EyeWorld symposium on […]